Botox Market Forecasts to 2030 – Global Analysis By Product Type (Botulinum Toxin B, Botulinum Toxin A and Other Product Types), Gender (Male and Female), Age Group, Application, End User and By Geography
Description
Botox Market Forecasts to 2030 – Global Analysis By Product Type (Botulinum Toxin B, Botulinum Toxin A and Other Product Types), Gender (Male and Female), Age Group, Application, End User and By Geography
According to Stratistics MRC, the Global Botox Market is accounted for $7.26 billion in 2023 and is expected to reach $17.63 billion by 2030 growing at a CAGR of 13.5% during the forecast period. A neurotoxic protein generated from the bacteria Clostridium botulinum is known as botox or botulinum toxin. It is used both medically and cosmetically to temporarily paralyze or relax muscles. It is also used to treat medical diseases such as hyperhidrosis, chronic headaches, muscle spasms, and movement abnormalities. Botox is administered by qualified medical personnel to prevent negative consequences, careful administration is crucial.
According to the America Society of Plastic Surgeon report, nearly 13% dip were observed in botulinum toxin procedures in 2020.
Market Dynamics
Driver
Rising demand in Botox injections
Botox injections have numerous other benefits, primarily enhancing physical appearance. For instance, Botox injections are frequently used to help people with temporomandibular joint (TMJ) or other types of muscle pain relax their muscles. Additionally, chronic health issues, including migraines, are treated with botox injections, it can reduce the excessive use of the muscles by blocking the activity of the muscles' nerves. Hence, botox injections can help those who experience excessive underarm sweating, urinary tract disorders, or an overactive bladder.
Restraint
High Costs
For many people, the high expense of (botulinum toxin) Botox, might be a substantial barrier. Access to the treatment may be hampered by the cost, especially for those without sufficient financial means or health insurance. Furthermore, this financial barrier may hinder people from taking advantage of the toxin's medicinal or aesthetic effects, which may lower their quality of life or lower their self-esteem. Thus, the cost burden is made higher by the ongoing nature of botox treatments, which often call for several sessions over time.
Opportunity
Increase in demand for non-invasive surgeries
People over the age of 40 tend to focus on their physical appearance and want to look young. Thus, it is projected that increasing female attention to aesthetic traits, particularly in developed nations, will accelerate the expansion of the demand for non-invasive surgeries. Additionally, botulinum toxin is utilized to treat a variety of aging-related problems, including crow's feet, glabellar lines, forehead lines, and others. People over 40 are therefore more likely to experience these indicators of aging. Therefore, botulinum toxin operations are becoming increasingly popular among people between the ages of 40 and 54, which are boosting market growth.
Threat
Side Effects
Botox procedures are well regarded for having fewer risks and few side effects that typically go away within 24-48 hours. Moreover, some people could experience adverse effects that can continue for weeks. Examples of these include nausea, droopy eyes, a stiff neck, headaches, and more. Therefore, allergic reactions have often occurred; as a result, individuals taking antibiotics should take extra care before receiving botox therapy.
Covid-19 Impact
The limitations and lockdown measures put in place to stop the virus's spread led to the temporary closure of numerous dermatological and beauty clinics, which restricted access to botox treatments. Botox injection demand decreased as a result of non-essential medical procedures, such as aesthetic procedures, being delayed or stopped. Additionally, the economic crisis brought on by the epidemic has caused people to face financial difficulties, which have pushed them to be more careful about spending money on elective cosmetic surgeries. Therefore, in overall, the COVID-19 pandemic has drastically impacted the market for Botox, leading to a decline in demand and sales for these procedures.
The dermatology clinics segment is expected to be the largest during the forecast period
The dermatology clinics segment is estimated to hold the largest share. Botulinum toxin is frequently administered in dermatology workplaces, especially when used cosmetically. Additionally, these clinics specialize in the diagnosis and treatment of various skin diseases and provide botulinum toxin injections, a well-liked non-surgical method for eradicating wrinkles and small lines on the face. Dermatologists have the skills to evaluate patients' needs, choose the right dosage, and properly administer injections because they are licensed medical professionals. Furthermore, a controlled and hygienic atmosphere is offered by dermatology clinics, which frequently draw clients looking for cosmetic improvements.
The therapeutics segment is expected to have the highest CAGR during the forecast period
The therapeutics segment is anticipated to have highest CAGR during the forecast period, due to a variety of therapeutic and preventive treatments, including those for persistent migraines, overactive bladders, and hyperhidrosis, are carried out using botox procedures. Additionally, enhanced knowledge of the many mechanisms of action and molar behaviour of botulinum toxin has expanded its therapeutic potential. Hyperhidrosis and recurrent headaches are only two of the many disorders that can be treated with botox. Therefore, these aspects drive the market’s growth.
Region with largest share
North America commanded the largest market share during the extrapolated period due to the rising disposable income, technological advancements in aesthetic botox procedures, and state-of-the-art facilities for surgery and treatment. Additionally, contributing to revenue growth in the area is the rising demand for cosmetic procedures, quick approvals, and verification of various botox treatments.
Region with highest CAGR
Europe is expected to witness profitable growth over the projection period, owing to the increased investment in R&D projects to launch new products is in the European region. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) (2021), 208,764 nonsurgical cosmetic procedures, including 75,348 botulinum toxin treatments, were performed in Spain. Additionally, the UK botulinum toxin market had the quickest rate of growth in the European region, while the German botulinum toxin market held the greatest market share.
Key players in the market
Some of the key players in the Botox Market include WorldMeds LLC., Syneron Candela, Solta Medical, AbbVie, Allergan Inc., Eisai Co., Ltd., Evolus, Inc.,Galderma S.A., Hugel, Inc, Ipsen Group, Lanzhou Institute of Biological Products Co. Ltd., Lumenis, Medy Tox Inc., Merz Pharma., Pfizer Inc., Revance Therapeutics Inc. and Solta Medical.
Key Developments
In October 2022, Galderma and National Breast Cancer Foundation Inc. (NBCF) kept on their collaboration. Breast cancer survivors who had Restylane, Dysport (abobotulinumtoxinA), and/or Sculptra during Breast Cancer Awareness Month were profiled in a promotion on Galderma's social media channels.
In August 2022, the collaboration between Medytox and Bloomage Biotechnology has ended. According to Bloomage Biotechnology, since the joint venture agreement was signed, Medytox has never offered goods made by Medybloom China BTX for sale.
In July 2022, Fastox Pharma debuted the long-lasting botulinum toxin, known as LAST technology, during the ""Toxins 2022 International Conference."" Fastox discovered that the commencement of action of botulinum toxin type A (BoNT/A) should be accelerated by the addition of fast-acting myorelaxant drugs.
Product Types Covered
• Botulinum Toxin B
• Botulinum Toxin A
• Other Product Types
Genders Covered
• Male
• Female
Age Groups Covered
• 13-19
• 20-29
• 30-39
• 40-54
• 55 and above
Applications Covered
• Therapeutics
• Aesthetics
• Other Applications
End Users Covered
• Spas and Cosmetic Centers
• Hospitals
• Dermatology Clinics
• Other End Users
Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Table of Contents
200 Pages
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Botox Market, By Product Type
- 5.1 Introduction
- 5.2 Botulinum Toxin B
- 5.3 Botulinum Toxin A
- 5.3.1 Dysport
- 5.3.2 Botox
- 5.3.3 Xeomin
- 5.4 Other Product Types
- 6 Global Botox Market, By Gender
- 6.1 Introduction
- 6.2 Male
- 6.3 Female
- 7 Global Botox Market, By Age Group
- 7.1 Introduction
- 7.2 13-19
- 7.3 20-29
- 7.4 30-39
- 7.5 40-54
- 7.6 55 and above
- 8 Global Botox Market, By Application
- 8.1 Introduction
- 8.2 Therapeutics
- 8.2.1 Overactive Bladder
- 8.2.2 Chronic Migraine
- 8.2.3 Spasticity
- 8.2.4 Cervical Dystonia
- 8.2.5 Other Therapeutics
- 8.3 Aesthetics
- 8.3.1 Glabellar Lines
- 8.3.2 Crow's Feet
- 8.3.3 Forehead Lines
- 8.3.4 Other Aesthetics
- 8.4 Other Applications
- 9 Global Botox Market, By End User
- 9.1 Introduction
- 9.2 Spas and Cosmetic Centers
- 9.3 Hospitals
- 9.4 Dermatology Clinics
- 9.5 Other End Users
- 10 Global Botox Market, By Geography
- 10.1 Introduction
- 10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
- 10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
- 10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa
- 11 Key Developments
- 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 11.2 Acquisitions & Mergers
- 11.3 New Product Launch
- 11.4 Expansions
- 11.5 Other Key Strategies
- 12 Company Profiling
- 12.1 WorldMeds LLC.
- 12.2 Syneron Candela
- 12.3 Solta Medical.
- 12.4 AbbVie
- 12.5 Allergan Inc.
- 12.6 Eisai Co., Ltd.
- 12.7 Evolus, Inc.
- 12.8 Galderma S.A.
- 12.9 Hugel, Inc
- 12.10 Ipsen Group
- 12.11 Lanzhou Institute of Biological Products Co. Ltd.
- 12.12 Lumenis
- 12.13 Medy Tox Inc.
- 12.14 Merz Pharma.
- 12.15 Pfizer Inc.
- 12.16 Revance Therapeutics Inc.
- 12.17 Solta Medical.
- List of Tables
- Table 1 Global Botox Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Botox Market Outlook, By Product Type (2021-2030) ($MN)
- Table 3 Global Botox Market Outlook, By Botulinum Toxin B (2021-2030) ($MN)
- Table 4 Global Botox Market Outlook, By Botulinum Toxin A (2021-2030) ($MN)
- Table 5 Global Botox Market Outlook, By Dysport (2021-2030) ($MN)
- Table 6 Global Botox Market Outlook, By Botox (2021-2030) ($MN)
- Table 7 Global Botox Market Outlook, By Xeomin (2021-2030) ($MN)
- Table 8 Global Botox Market Outlook, By Other Product Types (2021-2030) ($MN)
- Table 9 Global Botox Market Outlook, By Gender (2021-2030) ($MN)
- Table 10 Global Botox Market Outlook, By Male (2021-2030) ($MN)
- Table 11 Global Botox Market Outlook, By Female (2021-2030) ($MN)
- Table 12 Global Botox Market Outlook, By Age Group (2021-2030) ($MN)
- Table 13 Global Botox Market Outlook, By 13-19 (2021-2030) ($MN)
- Table 14 Global Botox Market Outlook, By 20-29 (2021-2030) ($MN)
- Table 15 Global Botox Market Outlook, By 30-39 (2021-2030) ($MN)
- Table 16 Global Botox Market Outlook, By 40-54 (2021-2030) ($MN)
- Table 17 Global Botox Market Outlook, By 55 and above (2021-2030) ($MN)
- Table 18 Global Botox Market Outlook, By Application (2021-2030) ($MN)
- Table 19 Global Botox Market Outlook, By Therapeutics (2021-2030) ($MN)
- Table 20 Global Botox Market Outlook, By Overactive Bladder (2021-2030) ($MN)
- Table 21 Global Botox Market Outlook, By Chronic Migraine (2021-2030) ($MN)
- Table 22 Global Botox Market Outlook, By Spasticity (2021-2030) ($MN)
- Table 23 Global Botox Market Outlook, By Cervical Dystonia (2021-2030) ($MN)
- Table 24 Global Botox Market Outlook, By Other Therapeutics (2021-2030) ($MN)
- Table 25 Global Botox Market Outlook, By Aesthetics (2021-2030) ($MN)
- Table 26 Global Botox Market Outlook, By Glabellar Lines (2021-2030) ($MN)
- Table 27 Global Botox Market Outlook, By Crow's Feet (2021-2030) ($MN)
- Table 28 Global Botox Market Outlook, By Forehead Lines (2021-2030) ($MN)
- Table 29 Global Botox Market Outlook, By Other Aesthetics (2021-2030) ($MN)
- Table 30 Global Botox Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 31 Global Botox Market Outlook, By End User (2021-2030) ($MN)
- Table 32 Global Botox Market Outlook, By Spas and Cosmetic Centers (2021-2030) ($MN)
- Table 33 Global Botox Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 34 Global Botox Market Outlook, By Dermatology Clinics (2021-2030) ($MN)
- Table 35 Global Botox Market Outlook, By Other End Users (2021-2030) ($MN)
- Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
